Bondipend Soft Capsule (Alfacalcidol)

Adult dose

For chronic renal failure and osteoporosis, alfacalcidol is administered orally once daily at 0.5–1 µg. For hypoparathyroidism and other diseases resulting from vitamin D metabolism disorders, this medication is administered orally once daily at 1–4 µg.

Child dose

For osteoporosis, alfacalcidol is administered orally once daily at 0.01–0.03 µg per kg of body weight. For other diseases, this medication is administered orally once daily at 0.05–0.1 µg per kg of body weight.

This medication should not be taken by patients with hypercalcemia, hyperphosphatemia, or hypermagnesemia. It should also be avoided in cases where the product of calcium and phosphorus in the blood exceeds a certain level or in cases of alkalosis. If there are symptoms of vitamin D overdose or if there is an allergy to this medication or its ingredients, it should be avoided. During the use of this medication, it should not be taken together with drugs containing magnesium, vitamin D preparations, calcium-containing preparations, and certain diuretics as it may cause dangerously high levels of calcium in the blood. Women who are breastfeeding may find it unsafe to take this medication, and it is recommended to avoid it if possible. If taking is unavoidable, it is advisable to stop breastfeeding. Women who are pregnant or may become pregnant should consult an expert before taking this medication. It is also important for children, the elderly, and patients taking certain medications to consult with healthcare professionals before taking this medication. During treatment, various symptoms related to hypercalcemia may occur, so if symptoms arise, immediately discontinue use and consult an expert. Especially, symptoms related to kidney dysfunction, liver dysfunction, skin rashes, and ocular abnormalities may appear. It is important to strictly adhere to the prescribed dosage and regimen while taking this medication and to pay attention to calcium intake. Regular testing of serum calcium levels to maintain them within the normal range is crucial. In case of overdose, discontinue use immediately and seek emergency treatment, and closely monitor until serum calcium levels return to normal. This medication should be stored out of reach of children, away from direct sunlight, and in a cool, dry place. For quality maintenance, it is advisable not to transfer it to other containers.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rashes with high fever, blisters, skin peeling, pain in mucous membranes of the mouth and eyes, severe skin reactions, shortness of breath or respiratory difficulty, asthma attacks, cough accompanied by fever-related respiratory abnormalities, respiratory issues, jaundice (yellowing of the skin or eyes), profound lethargy, liver abnormalities (jaundice), sudden and severe.

Mild side effects

• Loss of appetite
• nausea
• vomiting
• diarrhea
• constipation
• stomach pain
• gastric discomfort
• abdominal bloating
• indigestion
• thirst

This medication is sensitive to light, so it should be stored in light-blocking containers. Additionally, it is important to store it at room temperature between 1°C and 30°C to maintain its efficacy.

Appearance

Yellow oval soft capsule containing colorless or transparent oily contents

Package unit

30 capsules/bottle, 100 capsules/bottle